powerpoint

24
Chapter 4:Gene Function

Upload: pammy98

Post on 28-Nov-2014

642 views

Category:

Documents


1 download

DESCRIPTION

 

TRANSCRIPT

Page 1: Powerpoint

Chapter 4:Gene Function

Page 2: Powerpoint

Principal Points

There is a specific relationship between protein coding genes and the production of polypeptides (one gene-one polypeptide)

Many human genetic diseases are caused by deficiencies in enzyme activities (learn the ones reviewed in the chapter)

Genetic counseling consists of an analysis of the risk that prospective parents may produce a child with a genetic defect and what are the available options for avoiding or minimizing those risks. As part of this analysis a pedigree analysis- the study of a family tree- is performed.

Page 3: Powerpoint

Garrod’s HypothesisOf Inborn Errors of Metabolism: He studiedPatients with Alkaptonuria(urine that turns the colorBlack because of HA accumulation)

He also studied otherGenetic diseases thatWere the result of blocksIn a metabolic pathway

Page 4: Powerpoint

You may not “care” about bread mold BUT it is an excellent organism to figure out biochemical pathways—

Question: To isolate auxotrophs in this manner, would a scientist have to have some idea what the intermediates are in the biochemical pathway? Answer this question after reading about Beadle and Tatum’s experiment

Page 5: Powerpoint
Page 6: Powerpoint

Understand Beadle & Tatum’s experiment and the use of auxotrophic mutants to figure out an enzymatic pathway

Page 7: Powerpoint

From this table could you determine the metabolic pathway for theProduction of methionine?

Page 8: Powerpoint
Page 9: Powerpoint

Genetic Defects in Humans

What is the enzyme defect, location of the defect, symptoms, and treatments for the following genetic diseases:

Phenylketonuria AlbinismLesch-Nyhan syndromeTay-Sachs diseaseSickle Cell Cystic Fibrosis

Page 10: Powerpoint

What is OMIM?

Page 11: Powerpoint

Tay-Sachs

Page 12: Powerpoint

What is the specific mutation found in the most common form of sickle-cell anemia (Hb-S), and how does this defect affect the structure and function of the resulting polypeptide (primary, secondary, tertiary, and quantanary structure)

What are some of the different types of hemoglobin mutants have been discovered in human populations, and how do they differ from the Hb-S mutation?

It is a change in the 6th amino acid from Glu (polar) to Val (nonpolar) amino acid. This is a change in primary structure. Affects tertiary structure since polar amino acids form hydrogen bonds and ionic bonds and nonpolar do not. And definitely affects quantanary structure since mutated beta subunits can only associate with mutated subunits and not with normal beta subunits; both associate with normal alpha subunits.

Page 13: Powerpoint

Figure 4.8 Colorized scanning electron micrographs of (left) normal and (right) sickled red blood cells.

Page 14: Powerpoint

Why is Hb-S more positivelyCharged compared to Hb-A?

Figure 4.9 Electrophoresis of hemoglobin variants. Hemoglobin found (left) in normal subjects, (center) in subjects with sickle-cell trait, and (right) in subjects who exhibit sickle-cell anemia. The two hemoglobins migrate to different positions in an electric field and therefore must differ in electric charge. (WHY?)

Page 15: Powerpoint

The normal Hbmolecule

Figure 4.10 The hemoglobin molecule. The diagram shows the two polypeptides and two polypeptides, each of which is associated with a heme group.

Page 16: Powerpoint

Figure 4.11 The first seven N-terminal amino acids in normal and sickled hemoglobin polypeptides. There is a single amino acid change from glutamic acid to valine at the sixth position in the sickled hemoglobin polypeptide.

Page 17: Powerpoint

Figure 4.12 Examples of amino acid substitutions found in (a) and (b) polypeptides of various human hemoglobin variants; not all variants cause disease.

Page 18: Powerpoint

Discuss the genetic defect and its pleiotropic effects in cystic fibrosis.

What is the frequency of cyctic fibrosis defect birth rates in these populations: Caucasian, African-American, and Asian.

How did scientists deduce the function of the 1480-amino acid protein involved in cystic fibrosis?

What is the specific defect of the most common form of cystic fibrosis: F508. (Explain the annotation.)

The defective gene product in CF patients was identified, not by biochemical analysis, but by a combination of genetic and modern biology techniques. It was localized to chromosome 7 and then it was molecularly cloned from a normal subject and from patients with CF. The serious form is deletion of three consecutive base pairs in the ATP-binding region.

Page 19: Powerpoint

Figure 4.13 Child with cystic fibrosis having the back pounded to dislodge accumulated mucus in the lungs. Presently these children have an average life

Span of 35 years.

Page 20: Powerpoint

Figure 4.14 Proposed structure for cystic fibrosis transmembrane conductance regulator (CFTR). The protein has two hydrophobic segments that span the plasma membrane, and after each segment is a nucleotide-binding fold (NBF) region that binds ATP. The site of the amino acid deletion resulting from the threenucleotide- pair deletion in the CF gene most commonly seen in patients with severe cystic fibrosis is in the first (toward the amino end) NBF; this is the mutation. The central portion of the molecule contains sites that can be phosphorylated by the enzymes protein kinase A and protein kinase C.

Page 21: Powerpoint

Since carriers are heterozygotes that most often have a normal phenotype, what must be done in order to detect a carrier?

How can amniocentesis determine whether a fetus is normal?

Why is amniocentesis avoided and only resorted to in high-risk cases?

What allows chorionic villus sampling to test a fetus at an earlier stage of development?

What are two drawbacks to chorionic villus sampling, compared to amniocentesis?

Page 22: Powerpoint

Figure 4.15 Amniocentesis, a procedure used for prenatal diagnosis of genetic defects. It is done after the 12th week of gestation. Because it is complicated and costly, it is used primarily in high-risk cases, such as when a mother is over 35.

Page 23: Powerpoint

Done between the 8th and 12th weeks of pregnancy. Disadvantages are thePossibilities of fetal death and inaccurate diagnoses caused by the presenceOf maternal cells.

Page 24: Powerpoint

Google cystic fibrosis gene therapy and find out what has been did in this area of research—know this for the test!